If you need more lookups,
subscriptions start at $34 USD/month.
Lan Chen Location
Japan
Lan Chen Work
2024 -now TA ONC Lead JP, Senior Director @
2024 -2024 R and D Clinical Science Head @
2023 -2024 R and D CS ONC Head @
2021 -2023 Corporate TA ONC Asset Lead @
2020 -2021 Head of Specialty Care Medicine @
2019 -2020 TA Oncology Head @
2016 -2019 Medical Director for R and D @ Merck Serono
2013 -2016 Medical director for R and D @
2011 -2012 Medical Affairs Manager @
2007 -2011 Senior Scientist @
2002 -2003 International Researcher @ Nagoya Univ. medical school
1999 -2002 Resident @ Liaohe Petroleum Central Hospital
Lan Chen Education
King's College London, U. of London
(Clinical Pharmacology)
2011-2013
Nagoya Univ. Medical School
Ph.D (Molecular Biology)
2003-2007
China Medical University
M.D. (Clinical Medicine)
1994-1999
Lan Chen Skills
Medical Affairs
Cancer
Medicine
Clinical Development
Pharmacovigilance
Clinical Trials
Oncology
Pharmaceutical Industry
Clinical Research
Medical Education
Biochemistry
Social Media
Outlook
Public Speaking
Microsoft Word
Windows
Lan Chen Summary
Lan Chen, based in Japan, is currently a TA ONC Lead JP, Senior Director at Johnson & Johnson Innovative Medicine. Lan Chen brings experience from previous roles at The Janssen Pharmaceutical Companies of Johnson & Johnson and Boehringer Ingelheim. Lan Chen holds a 2011 - 2013 King's College London, U. of London. With a robust skill set that includes Medical Affairs, Cancer, Medicine, Clinical Development, Pharmacovigilance and more. Lan Chen has 3 emails on RocketReach.
Looking for a different Lan Chen?
Find contact details for 700 million professionals.